Patients with cystic fibrosis are often in a poor nutritional state and require dietary supplementation to meet the energy requirements of an increased basal metabolic rate.' As lung disease progresses, energy requirements increase further to meet the stress of pulmonary sepsis and increased work of breathing. 1-4 Dietary supplementation involves an overall increase in energy intake predominantly in the form of carbohydrate, the most efficient energy substrate.5,6 We report the metabolic and respiratory consequences of a glucose load, of equivalent energy value to that usually given to such patients as an overnight supplementary feed by fine bore nasogastric tube, in a hypoxic patient with cystic fibrosis who complained of breathlessness and lethargy after meals. CASE REPORT. A 28-year-old male with cystic fibrosis was referred for assessment of respiratory failure and cor pulmonale. Cystic fibrosis was diagnosed at the age of five months because of repeated respiratory tract infection and failure to thrive. Sweat sodium at that time was 78 mmol/l (normal < 40 mmol/l). He remained well until the age of 26 when after a severe pulmonary exacerbation he reported progressive shortness of breath. At admission he was cyanosed, arterial oxygen tension (PaO2) 5-9 kPa with hypercapnoea, arterial carbon dioxide tension (PaCO2) 6-85 kPa. There was marked pulmonary disease with finger clubbing, and bilateral coarse crepitations on examination. The Chrispin -Norman score based on changes on a chest radiograph was 21 points (O= no disease, 38= most severe).7 Sputum culture had regularly grown Pseudomonas aeruginosa for more than five years during which time he received intermittent courses of intravenous antibiotics. He was undernourished (47-1 kg; body mass index (BMI) 15-6 kg/m2); his Shwachman score was 40 points indicating an overall poor clinical condition (100 points= excellent; 40 or less = very severe).8 He had recently developed diabetes mellitus Respiratory Medicine Unit, City Hospital, Nottingham NG5 1 PB.
CASE REPORT. A 28-year-old male with cystic fibrosis was referred for assessment of respiratory failure and cor pulmonale. Cystic fibrosis was diagnosed at the age of five months because of repeated respiratory tract infection and failure to thrive. Sweat sodium at that time was 78 mmol/l (normal < 40 mmol/l). He remained well until the age of 26 when after a severe pulmonary exacerbation he reported progressive shortness of breath. At admission he was cyanosed, arterial oxygen tension (PaO2) 5-9 kPa with hypercapnoea, arterial carbon dioxide tension (PaCO2) 6-85 kPa. There was marked pulmonary disease with finger clubbing, and bilateral coarse crepitations on examination. The Chrispin -Norman score based on changes on a chest radiograph was 21 points (O= no disease, 38= most severe).7 Sputum culture had regularly grown Pseudomonas aeruginosa for more than five years during which time he received intermittent courses of intravenous antibiotics. He was undernourished (47-1 kg; body mass index (BMI) 15-6 kg/m2); his Shwachman score was 40 points indicating an overall poor clinical condition (100 points= excellent; 40 or less = very severe).8 He had recently developed diabetes mellitus which was controlled with glibenclamide 10 mg daily. He was initially commenced on a carbohydrate restricted diet, but due to weight loss the amount of carbohydrate was increased to provide extra energy and improve his nutritional state. Subsequently he reported symptoms of breathlessness, particularly after high carbohydrate meals. To investigate this breathlessness, prior to beginning overnight enteral feeding, he had a 75 gram glucose tolerance test (300 kcal) following an overnight fast. The response of plasma glucose, the resting carbon dioxide production (VCO2), oxygen uptake (V02), minute ventilation (VE) and capillary blood gas tensions were determined. Respiratory gas exchange (Gould Electronics) was measured for 10 minutes prior to each blood sample at 0, 60, 90, 120 and 180 minutes. Minute ventilation, oxygen uptake, carbon dioxide production and respiratory exchange ratio (RER) were calculated from mixed expired gas sampled every 20 seconds.9 The mean of measurement for the second five minutes of each period is reported. The coefficient of variation for each parameter (oxygen uptake, resting carbon dioxide production, minute ventilation and respiratory exchange ratio) was between 4-8% for each five minute period. The glucose tolerance test was repeated two days later while breathing oxygen (fraction of oxygen in the inspired air (F102) = 28 %) by face mask to determine whether this further elevated arterial carbon dioxide tension. The glucose load while breathing air caused a substantial increase in resting oxygen uptake, carbon dioxide production and the respiratory exchange ratio after two hours (Table) . Minute ventilation and respiratory rate also increased. Plasma glucose increased substantially at between one and two hours in parallel with an increase in arterial carbon dioxide tension. When repeated, breathing oxygen, a similar plasma glucose response occurred but with a higher arterial carbon dioxide tension and the patient was more dyspnoeic. The glucose tolerance test was repeated five days later with 12 units of insulin given 20 minutes prior to the glucose load. The rise in plasma glucose was less, increasing by 2 -5 mmol/l after 120 minutes and arterial carbon dioxide tension increased by 1-2 kPa. There was no difference in the blood gas responses when insulin was given compared to when not.
DISCUSSION
We have demonstrated potentially deleterious effects of an oral glucose challenge on resting metabolism and capillary blood gases in a diabetic patient with hypoxic chronic obstructive lung disease due to cystic fibrosis. Patients with cystic fibrosis are often markedly underweight and require nutritional support.1 5 Nutrition becomes a particular problem as lung function deteriorates and patients develop respiratory failure.' Such patients often require energy supplementation either by mouth or by fine bore nasogastric tube feeding. Many supplements are high in glucose and may represent a considerable metabolic load for patients already in respiratory failure.'0" 1 In ambulatory patients with chronic obstructive pulmonary disease, high carbohydrate diets increase dyspnoea and reduce exercise tolerance4 though these diets seem to have little effect on arterial carbon dioxide tension.12 In patients with respiratory failure in an intensive care unit, intravenous total parenteral nutrition with high glucose content feeds increases both carbon dioxide production and arterial carbon dioxide tension.6 In our patient with established respiratory failure the glucose load caused a similar increase in carbon dioxide production, arterial carbon dioxide tension and minute ventilation and resulted in symptoms of dyspnoea and sleepiness. A carbohydrate load, because of the high respiratory quotient (VC02/VO2) of glucose (RQ=1) is known to increase carbon dioxide production relative to oxygen uptake to a greater extent than fat (RQ = 0 * 7). 13 The increase in carbon dioxide production stimulates ventilatory receptors, increasing minute ventilation to prevent arterial carbon dioxide tension from rising. In patients with severe respiratory impairment the increase in ventilation may not be sufficient to remove the excess CO2 produced and so, as in this case, an increase in arterial carbon dioxide tension occurs. The observed increase in arterial oxygen tension after oral glucose has been noted before and is most likely due to an increase in alveolar ventilation.13 Diabetes mellitus occurs in 5-10% of adult patients with cystic fibrosis, and impaired glucose tolerance is seen in up to 50%.14, 15 Diabetes is usually controlled without much difficulty using oral hypoglycaemic agents or small doses of insulin. In our patient diabetes had not been a major problem and plasma glucose levels were never greatly elevated. The glucose load after 12 u of insulin did not result in a substantial difference in arterial tension of carbon dioxide when compared to glucose given alone. This suggests that diabetes did not contribute to changes in blood gases, and the abnormal pulmonary function was primarily responsible for the rise in arterial carbon dioxide tension. Although insulin did not normalise the plasma glucose responses to the glucose load, it is possible that the elevated glucose levels may have contributed to the patient's symptoms. However, it might be expected that insulin would increase carbon dioxide production by increasing the availability of intracellular glucose. This report demonstrates the value of assessing the blood gas response to an oral glucose tolerance test which contains a similar carbohydrate content to commercially available supplements for a single overnight tube feed. We had hoped to provide overnight enteral feeding and oxygen therapy together, but in view of the rise in arterial carbon dioxide tension following this combination and the patient's increased symptoms, we decided to use a high fat feed. Reduction in the proportion of carbohydrate in his diet in favour of fat and protein improved his postprandial dyspnoea. This case illustrates the need to consider the metabolic consequences of diet in patients with respiratory failure, particularly when consideration is being given to intensive energy supplementation. 
